Aziyo Biologics, Inc. (AZYO) Misses Q2 EPS by 36c

Aziyo Biologics, Inc. (NASDAQ: AZYO) reported Q2 EPS of ($0.65), $0.36 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $10.3 million versus the consensus estimate of $12.5 million.

For earnings history and earnings-related data on Aziyo Biologics, Inc. (AZYO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c